OpenAI Acquires Orchestra Bio to Enhance Biotech Software Capabilities
OpenAI announced the acquisition of Orchestra Bio, a four-year-old AI biotech software startup, to strengthen its biotech initiatives. The financial terms of the deal remain undisclosed, although Orchestra Bio had raised approximately $20 million by 2025 from investors such as Andreessen Horowitz, A...